---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-24-000041"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-03-07T23:59:59+00:00"
generated_at: "2026-06-05T01:47:59.613536+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GoodRx CFO Karsten Voermann enters new employment agreement, receives $5M equity and special bonus

## Summary
- New agreement sets base salary at $450,000, target bonus of 100% of salary, and $5M equity award (50% option, 50% RSU) vesting over 4 years.
- One-time special bonus of $162,792 for contributions to restructuring and management transition.
- Severance provides 12 months base salary, COBRA reimbursement, and accelerated vesting for 12 months if terminated without cause in change-of-control period.
- Voermann remains at-will and subject to confidentiality, non-solicitation covenants.

## SEC filing metadata
- accession: 0001809519-24-000041
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000041/0001809519-24-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000041/gdrx-8xkxitem502cfoagreeme.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-24-000041
- JSON: https://secwatch.observer/filing/0001809519-24-000041.json
- Plain text: https://secwatch.observer/filing/0001809519-24-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
